Similar articles

• The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience.

  Duffner PK, Horowitz ME, Krischer JP, Burger PC, Cohen ME, Sanford RA, Friedman HS, Kun LE. Duffner PK, et al. Neuro Oncol. 1999 Apr;1(2):152-61. doi: 10.1093/neuonc/1.2.152. Neuro Oncol. 1999. PMID: 11554387 Free PMC article. Review. No abstract available.
• Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.

  Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ. Thorarinsdottir HK, et al. Pediatr Blood Cancer. 2007 Mar;48(3):278-84. doi: 10.1002/pbc.20781. Pediatr Blood Cancer. 2007. PMID: 16456857
• High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.

  Pérez-Martínez A, Lassaletta A, González-Vicent M, Sevilla J, Díaz MA, Madero L. Pérez-Martínez A, et al. J Neurooncol. 2005 Jan;71(1):33-8. doi: 10.1007/s11060-004-4527-4. J Neurooncol. 2005. PMID: 15719272 Clinical Trial.
• Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.

  Sawamura Y, Ikeda J, Ishii N, Kato T, Tada M, Abe H, Shirato H. Sawamura Y, et al. Neurol Med Chir (Tokyo). 1996 Sep;36(9):632-8. doi: 10.2176/nmc.36.632. Neurol Med Chir (Tokyo). 1996. PMID: 8913079
• Pediatric central nervous system tumors.

  Reddy AT, Packer RJ. Reddy AT, et al. Curr Opin Oncol. 1998 May;10(3):186-93. doi: 10.1097/00001622-199805000-00003. Curr Opin Oncol. 1998. PMID: 9619353 Review.